Is retinol safe during pregnancy? What the research shows

Retinol has not been studied on its own

Bottom line: there is no study of retinol in pregnancy as its own category. Most of the human data we found covers prescription topical retinoids, including tretinoin, adapalene and tazarotene. Retinol is a weaker retinoid precursor, so those findings cannot be assumed to carry over to retinol cosmetics without direct evidence.

The label is the practical problem. Mayo Clinic notes that retinoids are sold both with and without a prescription, and that only small amounts are absorbed, which is why it still advises avoiding them during pregnancy.

The newest evidence is reassuring, but thin

Bottom line: the strongest study we found is a 2025 systematic review and meta-analysis, and it did not show a higher risk. It pooled eight studies covering 3,632,118 pregnancies, with the full review reporting the following for first-trimester topical retinoid exposure.

• Major congenital malformations: RR 0.83 (95% CI 0.64 to 1.07), not statistically significant
• Spontaneous abortion: RR 0.99 (95% CI 0.68 to 1.43), not statistically significant
• Only 2,648 exposed pregnancies contributed to the malformation analysis
• Dropping one study changed the malformation estimate by 29.6%

A Bayesian analysis gave a 74.1% posterior probability favoring no effect. That is not certainty. The malformation result leaned heavily on one study, and the intervals include small increases in risk, so the data cannot rule them out.

A prospective cohort shows the tradeoffs

Bottom line: a European teratology-network study found no significant difference in birth defects, but exposed women ended pregnancies electively about three times as often. The study compared 235 women exposed to topical retinoids in the first trimester with 444 controls, as described in the multicenter prospective study.

Spontaneous abortion (OR 1.5), minor birth defects (OR 1.3) and major birth defects (OR 1.8) were not significantly different between groups, and no child had features of retinoid embryopathy. Elective termination was higher in the exposed group (OR 3.4, 95% CI 1.5 to 7.8). The authors said the risk-benefit balance remained questionable and did not advise use in pregnancy.

What guidance still says, and why

Bottom line: guidance still favors avoidance, mostly as a precaution. The American Academy of Dermatology acne guideline says no human studies have established a causal link between topical retinoids and birth defects, but prefers non-retinoid topical therapies during pregnancy. It calls tazarotene contraindicated, based on animal studies, retinoid pharmacology and possible absorption.

Narrative reviews add nuance. One notes that topical retinoids have low systemic absorption, while oral isotretinoin and acitretin are strictly contraindicated, as summarized in a narrative review of skin and pregnancy. Another found no increased major malformation risk for tretinoin or adapalene in any trimester, but called the tazarotene and trifarotene data sparse, per a narrative review of acne treatment in pregnancy.

What to do if you are pregnant or planning

Bottom line: stop retinol and retinoid products once you know you are pregnant, and plan to stop before you try to conceive. Talk to your OB or dermatologist about non-retinoid options, which the acne guideline prefers during pregnancy.

Do not confuse topical retinoids with oral vitamin A or oral retinoids. Oral isotretinoin and acitretin are strictly contraindicated in pregnancy, and very high-dose oral vitamin A carried a much larger risk signal than any topical product. The reassuring numbers describe creams, not a green light for retinol.